These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 9824949)
1. [Chronic hepatitis C--therapeutic modalities for interferon failure]. Hermann R Praxis (Bern 1994); 1998 Oct; 87(42):1413-20. PubMed ID: 9824949 [TBL] [Abstract][Full Text] [Related]
2. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus. Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476 [TBL] [Abstract][Full Text] [Related]
3. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. Khalili M; Denham C; Perrillo R Am J Gastroenterol; 2000 May; 95(5):1284-9. PubMed ID: 10811340 [TBL] [Abstract][Full Text] [Related]
5. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)]. Juszczyk J; Bolewska B; Flieger J; Swietek K; Adamek B; Biskupska-Karasińska M; Dziambor AP; Boroń-Kaczmarska A; Wawrzynowicz-Syczewska M; Cianciara J; Kozłowska J; Daniluk J; Słomka M; Dudziak M; Zaborowski P; Gładysz A; Piszko P; Gonciarz Z; Mazur W; Machniak M; Kryczka W; Zarebska-Michaluk D; Trocha H; Witczak-Malinowska K; Lakomy E; Kuydowicz J; Niwicka-Michałowska A Pol Merkur Lekarski; 2001 Oct; 11(64):340-3. PubMed ID: 11770315 [TBL] [Abstract][Full Text] [Related]
7. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations]. Zarebska-Michaluk D; Lebensztejn DM; Kryczka W Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393 [TBL] [Abstract][Full Text] [Related]
9. Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone. Milella M; Santantonio T; Pietromatera G; Maselli R; Casalino C; Mariano N; Genchi C; Pastore G Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):211-5. PubMed ID: 10379482 [TBL] [Abstract][Full Text] [Related]
10. Use of high-dose interferon in the treatment of chronic hepatitis C. Shiffman ML Semin Liver Dis; 1999; 19 Suppl 1():25-33. PubMed ID: 10349690 [TBL] [Abstract][Full Text] [Related]
11. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders. Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198 [TBL] [Abstract][Full Text] [Related]
12. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection. Sulkowski MS; Wasserman R; Brooks L; Ball L; Gish R J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326 [TBL] [Abstract][Full Text] [Related]
13. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988 [TBL] [Abstract][Full Text] [Related]
14. [Retreatment of patients with chronic hepatitis C]. Ostojić R Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242 [TBL] [Abstract][Full Text] [Related]
15. [Interferon-alpha plus ribavirin combination therapy in chronic hepatitis C]. Sarrazin C; Zeuzem S Z Gastroenterol; 1999 Jul; 37(7):669-74. PubMed ID: 10458015 [No Abstract] [Full Text] [Related]
16. Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response. Sethi A; Shiffman ML Clin Liver Dis; 2005 Aug; 9(3):453-71, vii-viii. PubMed ID: 16023977 [TBL] [Abstract][Full Text] [Related]
17. [Indications for combination interferon-ribavirin therapy in chronic hepatitis C]. Blum HE Internist (Berl); 1998 Sep; 39(9):981. PubMed ID: 9788122 [No Abstract] [Full Text] [Related]
18. Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon alpha--hype or hope? Vogel W Wien Klin Wochenschr; 2004 Aug; 116(15-16):508-10. PubMed ID: 15471176 [No Abstract] [Full Text] [Related]
19. [Therapy of chronic hepatitis C: facing a breakthrough?]. Renner EL Schweiz Med Wochenschr; 1998 Jan; 128(1-2):15-7. PubMed ID: 9491462 [No Abstract] [Full Text] [Related]
20. Interferon-induced anosmia in a patient with chronic hepatitis C. Maruyama S; Hirayama C; Kadowaki Y; Sagayama A; Omura H; Nakamoto M Am J Gastroenterol; 1998 Jan; 93(1):122-3. PubMed ID: 9448193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]